Camlin Fine Sciences MD, chairman and AGM
NSE: CAMLINFINEBSE: 532834Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹83.75.
28 Oct: open ₹84.30, high ₹85.59, low ₹82.75
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,615 Cr1,056th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 274.49
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹29 crore of one-off items, the largest of them in the quarter to Mar 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹29 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.67
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,54,92545.0% delivered
Camlin Fine Sciences' chairperson and managing director is Ashish Subhash Dandekar and its managing director Nirmal Vinod Momaya, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 11 Aug 2026.
Camlin Fine Sciences board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorAshish Subhash DandekarRelated to the promoter
- Managing directorNirmal Vinod Momaya
- Company Secretary and Compliance OfficerRahul Sawale
13 directors7 independent3 executive3 non-executive
- Ashish Subhash Dandekar · Chairperson and managing directorExecutive · joined Jan 2007 · reappointed Aug 2024 · 36 months as independent · 1 listed board · 1 committee seat
- Anagha Subhash DandekarNon-executive · joined Aug 2018 · 1 listed board
- Nirmal Vinod Momaya · Managing directorExecutive · joined Aug 2014 · reappointed Jun 2024 · 36 months as independent · 2 listed boards · 1 as independent · 2 committee seats
- Arjun Sudhakar DukaneExecutive · joined Jun 2018 · reappointed Jun 2024 · 36 months as independent · 1 listed board
- Amol Jashvant ShahIndependent · joined Aug 2019 · reappointed Aug 2024 · 60 months as independent · 1 listed board · 1 as independent · 1 committee seat
- Harsha RaghavanNon-executive · joined Aug 2020 · reappointed Aug 2025 · 4 listed boards · 3 committee seats
- Josephconrad Agnelo DsouzaIndependent · joined Sep 2020 · reappointed Sep 2025 · 60 months as independent · 6 listed boards · 6 as independent · 10 committee seats, 5 as chair
- M G PalekarIndependent · joined Dec 2020 · reappointed Dec 2025 · 60 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 1 as chair
- Pradip Manilal KanakiaIndependent · joined Oct 2021 · 60 months as independent · 6 listed boards · 6 as independent · 7 committee seats, 4 as chair
- Abeezar E FaizullabhoyIndependent · joined Feb 2025 · 60 months as independent · 1 listed board · 1 as independent · 1 committee seat
- Jens Van NieuwenborghNon-executive · joined Mar 2025 · 2 listed boards · 1 committee seat
- Radhika Madhukar DudhatIndependent · joined Mar 2025 · 60 months as independent · 4 listed boards · 4 as independent · 6 committee seats, 1 as chair
- Atul PradhanIndependent · joined Sep 2026 · 60 months as independent · 1 listed board · 1 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
1 director who left
- Sutapa Banerjee, left 6 Feb 2025: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 11 Aug 202611 of 12 present5 independent · 76 days in between
- 26 May 202612 of 12 present6 independent
Audit Committee
Chair Pradip Manilal Kanakia
Amol Jashvant Shah, Harsha Raghavan, M G Palekar, Josephconrad Agnelo Dsouza, Abeezar E Faizullabhoy, Jens Van Nieuwenborgh, Radhika Madhukar Dudhat
- 11 Aug 20267 of 8 present5 independent · 76 days in between
- 26 May 20268 of 8 present6 independent
Nomination and remuneration committee
Chair Josephconrad Agnelo Dsouza
Pradip Manilal Kanakia, Amol Jashvant Shah, Harsha Raghavan, M G Palekar, Abeezar E Faizullabhoy, Jens Van Nieuwenborgh, Radhika Madhukar Dudhat
No meeting listed in the filing.
Stakeholders Relationship Committee
Chair M G Palekar
Ashish Subhash Dandekar, Nirmal Vinod Momaya, Radhika Madhukar Dudhat
No meeting listed in the filing.
Risk Management Committee
Chair Amol Jashvant Shah
Nirmal Vinod Momaya, Arjun Sudhakar Dukane, M G Palekar
- 11 Aug 20263 of 4 present1 independent · 178 days in between
- 13 Feb 20264 of 4 present2 independent
Corporate Social Responsibility Committee
Chair M G Palekar
Nirmal Vinod Momaya, Ashish Subhash Dandekar
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Kalyaniwalla and Mistry LLPPeer-review certificate valid to Jul 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Camlin Fine Sciences AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Camlin Fine Sciences dividend history
Postal ballot, 16 Oct 2026
58,383 shareholders on the register on 11 Sep 2026; votes counted by Sohan J. Ranade / JHR & Associates, Practicing Company Secretaries.The company's voting result
- Appointment of Mr. Atul Pradhan (DIN:00171022) as a Non-Executive Independent Director of the Company w.e.f. September 11, 2026.Special99.97% for0.03% against
Against: promoters 0.00% · institutions 0.00% · other public 0.57%
Turnout: all 56.13% · promoters 100.00% · institutions 86.28% · other public 6.11%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 11 Aug 2026, 4 resolutions
56,339 shareholders on the register on 5 Aug 2026; present: 7 promoters and 48 others; votes counted by J H RANADE / JHR & ASSOCIATES.The company's voting result
To consider and adopt (a) the audited financial statement of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon; and (b) the audited consolidated financial statement of the Company for the financial year ended March 31, 2026 and the report of the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 56.83% · promoters 100.00% · institutions 84.34% · other public 7.44%
- To re-appoint Mr. Harsha Raghavan (DIN: 01761512), who retires by rotation as a Non-Executive Non-Independent Director of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 56.86% · promoters 100.00% · institutions 84.75% · other public 7.44%
- To re-appoint Mr. Jens Van Nieuwenborgh (DIN: 07638244), who retires by rotation as a Non-Executive Non-Independent Director of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 56.86% · promoters 100.00% · institutions 84.75% · other public 7.44%
- To ratify the remuneration of the Cost Auditor for the financial year ending March 31, 2027.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 56.86% · promoters 100.00% · institutions 84.75% · other public 7.44%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 7 May 2026, 1 resolution
53,231 shareholders on the register on 3 Apr 2026; votes counted by Jayant H. Ranade / JHR & Associates, Practicing Company Secretaries.The company's voting result
- Increase in Authorized Share Capital and Consequent Amendment to Clause V of the Memorandum of Association of the Company.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.23%
Turnout: all 57.90% · promoters 100.00% · institutions 83.33% · other public 6.01%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 13 Dec 2025, 1 resolution
58,165 shareholders on the register on 7 Nov 2025; votes counted by Sohan J. Ranade / JHR & Associates, Practicing Company Secretaries.The company's voting result
- To re-appoint Mr. Mahabaleshwar G. Palekar (DIN: 02455892) as a Non-Executive Independent Director of the Company for a second term of five consecutive years.Special99.97% for0.03% against
Against: promoters 0.00% · institutions 0.18% · other public 0.75%
Turnout: all 47.33% · promoters 81.61% · institutions 74.40% · other public 1.36%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 29 Oct 2025, 1 resolution
59,191 shareholders on the register on 26 Sep 2025; votes counted by J H RANADE / JHR & ASSOCIATES.
- ISSUANCE OF EQUITY SHARES OF CAMLIN FINE SCIENCE LIMITED (THE “COMPANY”) ON A PREFERENTIAL BASIS PURSUANT TO A SHARE SWAP ARRANGEMNETSpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.16%
Turnout: all 57.11% · promoters 100.00% · institutions 71.34% · other public 6.04%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 17 Sep 2025, 1 resolution
59,905 shareholders on the register on 14 Aug 2025; votes counted by Jayant H Ranade / JHR & Associates, Practicing Company Secretaries.The company's voting result
- To re-appoint Mr. Joseph Conrad D’Souza (DIN: 00010576) as a Non-Executive Independent Director of the Company for a second term of five consecutive years.Special99.91% for0.09% against
Against: promoters 0.00% · institutions 0.90% · other public 0.85%
Turnout: all 54.36% · promoters 100.00% · institutions 63.64% · other public 1.29%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 8 Aug 2025, 6 resolutions
59,200 shareholders on the register on 2 Aug 2025; present: 5 promoters and 49 others; votes counted by J H RANADE / JHR & ASSOCIATES.The company's voting result
To consider and adopt (a) the audited financial statement of the Company for the financial year ended March 31, 2025 and the reports of the Board of Directors and Auditors thereon; and (b) the audited consolidated financial statement of the Company for the financial year ended March 31, 2025 and the report of the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 56.35% · promoters 99.99% · institutions 63.89% · other public 5.69%
- To re-appoint Mr. Arjun Dukane (DIN: 06820240), who retires by rotation as an Executive Director – Technical of the Company.Ordinary99.97% for0.03% against
Against: promoters 0.00% · institutions 0.30% · other public 0.03%
Turnout: all 56.38% · promoters 99.99% · institutions 64.25% · other public 5.69%
- To re-appoint Ms. Anagha Dandekar (DIN: 07897205), who retires by rotation as a Non-Executive Non-Independent Director of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.03% · other public 0.03%
Turnout: all 56.38% · promoters 99.99% · institutions 64.25% · other public 5.69%
- To ratify the remuneration of the Cost Auditor for the financial year ending March 31, 2026.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 56.38% · promoters 99.99% · institutions 64.25% · other public 5.69%
To appoint M/s. JHR & Associates, Practicing Company Secretaries, a peer reviewed firm (Firm registration number: S2015MH296800 / Peer Review Certificate No. 6285/2024), as Secretarial Auditors of the Company for a term of five (5) consecutive years.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 56.38% · promoters 99.99% · institutions 64.25% · other public 5.69%
- To re-appoint Mr. Harsha Raghavan (DIN: 01761512) as a Non-Executive Non-Independent Director of the Company, being liable to retire by rotation with effect from August 10, 2025.Ordinary99.92% for0.08% against
Against: promoters 0.00% · institutions 0.88% · other public 0.04%
Turnout: all 56.38% · promoters 99.99% · institutions 64.25% · other public 5.69%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 23 Apr 2025, 4 resolutions
57,169 shareholders on the register on 21 Mar 2025; votes counted by Sohan J. Ranade / JHR & Associates.The company's voting result
- Appointment of Mr. Abeezar Faizullabhoy (DIN: 00264422) as a Non-Executive Independent Director of the Company.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.25%
Turnout: all 55.54% · promoters 100.00% · institutions 76.71% · other public 5.21%
- Appointment of Ms. Radhika Dudhat (DIN: 00016712) as a Non-Executive Independent Director of the Company.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.12%
Turnout: all 55.54% · promoters 100.00% · institutions 76.71% · other public 5.21%
- Appointment of Mr. Jens Van Nieuwenborgh (DIN: 07638244) as a Non-Executive Non-Independent Director of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.08%
Turnout: all 55.54% · promoters 100.00% · institutions 76.71% · other public 5.21%
- Modification of the Camlin Fine Sciences Employee Stock Option Plan 2021.Special94.49% for5.51% against
Against: promoters 0.00% · institutions 74.99% · other public 0.26%
Turnout: all 55.54% · promoters 100.00% · institutions 76.71% · other public 5.21%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 11 Aug 2026, 3 fund houses
To consider and adopt (a) the audited financial statement of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon; and (b) the audited consolidated financial statement of the Company for the financial year ended March 31, 2026 and the report of the Auditors thereon.MoreLess
3 for0 against- To re-appoint Mr. Harsha Raghavan (DIN: 01761512), who retires by rotation as a Non-Executive Non-Independent Director of the Company.3 for0 against
- To re-appoint Mr. Jens Van Nieuwenborgh (DIN: 07638244), who retires by rotation as a Non-Executive Non-Independent Director of the Company.3 for0 against
- To ratify the remuneration of the Cost Auditor for the financial year ending March 31, 2027.3 for0 against
Mutual fund votes, meeting of 7 May 2026, 4 fund houses
- Increase in Authorized Share Capital and Consequent Amendment to Clause V of the Memorandum of Association of the Company.4 for0 against
Mutual fund votes, meeting of 13 Dec 2025, 4 fund houses
1 proposal
- To re-appoint Mr. Mahabaleshwar G. Palekar (DIN: 02455892) as a Non-Executive Independent Director of the Company for a second term of five consecutive years.4 for0 against
Mutual fund votes, meeting of 29 Oct 2025, 5 fund houses
1 proposal
- ISSUANCE OF EQUITY SHARES OF CAMLIN FINE SCIENCE LIMITED (THE “COMPANY”) ON A PREFERENTIAL BASIS PURSUANT TO A SHARE SWAP ARRANGEMNET
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundCompliant with law. Governance & Transparency Concern: Non-Disclosure of Valuation Report; fair value of the Equity Shares of the Target Company has not been disclosed / included in the Notice – Shareholders will not be able to ascertain the fairness of the Issue Price, and the overall transaction.
4 for1 against
Mutual fund votes, meeting of 17 Sep 2025, 5 fund houses
1 proposal
- To re-appoint Mr. Joseph Conrad D’Souza (DIN: 00010576) as a Non-Executive Independent Director of the Company for a second term of five consecutive years.5 for0 against
Mutual fund votes, meeting of 8 Aug 2025, 5 fund houses
6 proposals
To consider and adopt (a) the audited financial statement of the Company for the financial year ended March 31, 2025 and the reports of the Board of Directors and Auditors thereon; and (b) the audited consolidated financial statement of the Company for the financial year ended March 31, 2025 and the report of the Auditors thereon.MoreLess
5 for0 against- To re-appoint Mr. Arjun Dukane (DIN: 06820240), who retires by rotation as an Executive Director – Technical of the Company.5 for0 against
- To re-appoint Ms. Anagha Dandekar (DIN: 07897205), who retires by rotation as a Non-Executive Non-Independent Director of the Company.5 for0 against
- To ratify the remuneration of the Cost Auditor for the financial year ending March 31, 2026.5 for0 against
To appoint M/s. JHR & Associates, Practicing Company Secretaries, a peer reviewed firm (Firm registration number: S2015MH296800 / Peer Review Certificate No. 6285/2024), as Secretarial Auditors of the Company for a term of five (5) consecutive years.MoreLess
5 for0 against- To re-appoint Mr. Harsha Raghavan (DIN: 01761512) as a Non-Executive Non-Independent Director of the Company, being liable to retire by rotation with effect from August 10, 2025.5 for0 against
Mutual fund votes, meeting of 23 Apr 2025, 2 fund houses
4 proposals
- Appointment of Mr. Abeezar Faizullabhoy (DIN: 00264422) as a Non-Executive Independent Director of the Company.2 for0 against
- Appointment of Ms. Radhika Dudhat (DIN: 00016712) as a Non-Executive Independent Director of the Company.2 for0 against
- Appointment of Mr. Jens Van Nieuwenborgh (DIN: 07638244) as a Non-Executive Non-Independent Director of the Company.2 for0 against
- Modification of the Camlin Fine Sciences Employee Stock Option Plan 2021.
Against ICICI Prudential Mutual Fund
- ICICI Prudential Mutual FundEarlier there was a reference to the first lot of grants to be issued at an Exercise Price of ₹ 150/- per option, same is proposed to be deleted. ESOP scheme needs to be more broad based rather than distribution which is skewed largely towards 1 person (Mr. Nirmal Momaya was given ~85% of the previous option pool). Hence, the AMC has voted against the resolution.
1 for1 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Tax disputes
Reported in the filing for the quarter to Sep 2026.
- Tax disputeCustoms, Excise and Secrvice Tax Appellate TribunalSince 13 Apr 2017The Company has filed an appeal against the order before the Customs, Excise and Service Tax Appellate Tribunal ("CESTAT") and the matter is pending for hearing.
At the filing before: Order was received from the Commissioner of Central Excise, Thane II before the CESTAT regarding the demand of Excise Duty in view of rejection of remission of central excise duty claim amounting to Rs. 35.60 million under the Central Excise Act, 1944 and Customs Act, 1962 for the goods destroyed in the fire incident.MoreLess
- Tax disputeCommisioner of Income TaxSince 29 Jun 2021The Company has filed an appeal against the order before the Commissioner of Income Tax (Appeals) and the matter is pending for hearing.At the filing before: Order was received from the Assessing Officer of Income Tax on the assessment proceedings for the financial year 2016-17 regarding the demand of Rs. 60.72 million.
- Tax disputeCommisioner of Income TaxSince 22 Jan 2022The Company has filed an appeal against the order before the Commissioner of Income Tax (Appeals) and the matter is pending for hearing.
At the filing before: Order was received from the Assessing Officer of Income Tax on the assessment proceedings for the financial year 2017-18 under Section 271 G of the Income Tax Act, 1961 with respect to the Transfer Pricing Assessing Officer levying a penalty of Rs. 59.32 million.MoreLess
- Tax disputeCommisioner of Income TaxSince 30 Mar 2022
The Company has filed an appeal against the order before the Commissioner of Income Tax (Appeals) and the matter is pending for order giving effect against order issued by Commissioner of Income Tax (Appeals).MoreLess
At the filing before: Order was received from the Assessing Officer of Income Tax on the assessment proceedings for the financial year 2015-16 regarding the demand of Rs. 48.03 million. The appeal has been allowed, resulting in a reduced demand to Rs. 42.5 million.MoreLess
- Tax disputeCommisioner of Income TaxSince 29 Sep 2023The Company has filed an appeal against the order before the Commissioner of Income Tax (Appeals) and the matter is pending for hearing.
At the filing before: Order was received from the Assessing Officer of Income Tax regarding the demand of Rs.31.96 million on the assessment with respect to return of income filed for the financial year 2019-20 pursuant to additions made on account of Transfer Pricing order and Disallowance of certain deductions.MoreLess
- Tax disputeAdditional Commissioner, Office of the Commissioner of CGST & Central Excise, PalgharSince 31 Jan 2025The Company has filed an appeal against the order before the Commissioner of C. & C.E. (Appeal - III) and the hearing was held on 06-05-2026 but no further communication has been received.
At the filing before: Order was received from the Additional Commissioner, Office of the Commissioner of CGST & Central Excise, Palghar under the provisions of Section 74(9) the CGST Act, 2017 and the Corresponding entry of IGST Act, 2017, for the demand of amounting to Rs. 64.32 million.MoreLess
- Tax disputeAdditional Commissioner, by the Office of the Commissioner of CGST & Central Excise, Palghar CommissionerateSince 16 Mar 2026Petition filed with Hon’ble Bombay High Court.
At the filing before: An order has been issued under Section 74(9) of CGST Act 2017 read with section 20 of the IGST Act, 2017 and the relevant provisions of MGST Act 2017 regarding the availment of ineligible Input Tax Credit related to trade payables outstanding for more than 180 days during FY 2019-20 to FY 2022-23, for demand of Rs.235.42 million for ineligible ITC.MoreLess
- Tax disputeAssessment Unit, Income Tax DepartmentSince 4 Apr 2026The Company has filed an appeal against the order before the Commissioner of Income Tax (Appeals) and the matter is pending for hearing.
At the filing before: An Assessment Order under section 143(3) of the Income-Tax Act, 1961, for the Assessment Year 2023-24 has been issued, wherein a demand has been received directing to deposit a sum Rs. 54.70 million within 30 days of the service of this notice. The said demand is on account of Arm’s Length Price adjustment with regard to the value of international/domestic transactions entered into by the Company with its Associated Enterprises.MoreLess
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Mar 2026. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Rights IssuesJan 2025, checked by India Ratings & Research Private Limited | 224.69 | Prepayment and / or repayment, in full or in part, of certain borrowings availed by the Company | 169.05 | 169.05 | No |
| Rights IssuesJan 2025, checked by India Ratings & Research Private Limited | 224.69 | General corporate purposes | 54.94 | 54.94 | No |
| Rights IssuesJan 2025, checked by India Ratings & Research Private Limited | 224.69 | Issue related expenses | 0.69 | 0.69 | No |